Evaluation of fungal-specific fluorescent labeled echinocandin probes as diagnostic adjuncts.

The diagnosis of invasive fungal infections from radiographic imaging is non-specific and problematic. As a first step toward increasing specificity, we describe the development of a broad-spectrum fungal-specific targeting molecule, which when modified with a fluorescent label fully retains its targeting properties, and provides a basis for future imaging applications.

[1]  W. Melchers,et al.  Evaluation of Aspergillus PCR Protocols for Testing Serum Specimens , 2011, Journal of Clinical Microbiology.

[2]  D. Perlin.  Echinocandin-Resistant Candida: Molecular Methods and Phenotypes , 2011 .

[3]  J. Smith,et al.  High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  D. Perlin.  Current perspectives on echinocandin class drugs. , 2011, Future microbiology.

[5]  J. Cleary,et al.  Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint , 2009, Antimicrobial Agents and Chemotherapy.

[6]  J. Verhaegen,et al.  Prospective clinical evaluation of lower cut‐offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients , 2004, British journal of haematology.

[7]  S. Balajee,et al.  Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. , 2004, The Journal of infectious diseases.

[8]  E. Estey,et al.  β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome , 2004 .

[9]  P. Bruzzi,et al.  False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  L. Wheat.  Rapid diagnosis of invasive aspergillosis by antigen detection , 2003, Transplant infectious disease : an official journal of the Transplantation Society.

[11]  D. Denning.  Echinocandin antifungal drugs , 2003, The Lancet.

[12]  J. Verhaegen,et al.  Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. , 2001, Blood.

[13]  D. Kontoyiannis,et al.  Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). , 2006, Haematologica.

[14]  R. Greene,et al.  The radiological spectrum of pulmonary aspergillosis. , 2005, Medical mycology.

[15]  E. Estey,et al.  Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Nina Singh,et al.  Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.